Page last updated: 2024-08-17

tert-butylhydroperoxide and Capillary Leak Syndrome

tert-butylhydroperoxide has been researched along with Capillary Leak Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bouskela, E; Cyrino, FZ; Lerond, L; Svensjö, E	1

Other Studies

1 other study(ies) available for tert-butylhydroperoxide and Capillary Leak Syndrome

Article	Year
Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol. International journal of microcirculation, clinical and experimental, 1997, Volume: 17 Suppl 1 Topics: Administration, Oral; Animals; Capillary Leak Syndrome; Capillary Permeability; Cricetinae; Diosmin; Dose-Response Relationship, Drug; Male; Mesocricetus; Peroxides; Reactive Oxygen Species; tert-Butylhydroperoxide; Vitamin E	1997

Article

Year

Oxidant-induced increase in vascular permeability is inhibited by oral administration of S-5682 (Daflon 500 mg) and alpha-tocopherol.

International journal of microcirculation, clinical and experimental, 1997, Volume: 17 Suppl 1

Topics: Administration, Oral; Animals; Capillary Leak Syndrome; Capillary Permeability; Cricetinae; Diosmin; Dose-Response Relationship, Drug; Male; Mesocricetus; Peroxides; Reactive Oxygen Species; tert-Butylhydroperoxide; Vitamin E

1997